Fraud and corruption cost pharma 2.6% of revenues
This article was originally published in Scrip
Executive Summary
Healthcare, pharmaceutical and biotechnology companies on average lost 2.6% of their revenues because of fraud, according to the Global Fraud Report 2011/2012, conducted by the Economist Intelligence Unit. The pharma/biotech sector registered the second highest percentage loss of any industry, with only financial services companies faring worse.